SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043877
Filing Date
2019-11-19
Accepted
2019-11-19 16:06:52
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-10q_20190930.htm   iXBRL 10-Q 3367052
2 EX-31.1 vir-ex311_8.htm EX-31.1 17068
3 EX-31.2 vir-ex312_9.htm EX-31.2 17064
4 EX-32.1 vir-ex321_6.htm EX-32.1 9695
  Complete submission text file 0001564590-19-043877.txt   10595268

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vir-20190930.xsd EX-101.SCH 71854
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vir-20190930_cal.xml EX-101.CAL 53901
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vir-20190930_def.xml EX-101.DEF 293280
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20190930_lab.xml EX-101.LAB 548723
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20190930_pre.xml EX-101.PRE 441557
67 EXTRACTED XBRL INSTANCE DOCUMENT vir-10q_20190930_htm.xml XML 1815692
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 191231190
SIC: 2836 Biological Products, (No Diagnostic Substances)